Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK1 | P06493 | 18/20 | 0.76 |
| ▸ | KDR | P35968 | 18/20 | 0.76 |
| ▸ | CAMK2D | Q13557 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14816373 | 0.88 | CDK1 (0.74) | CDK1KDR | |
| SCHEMBL14816370 | 0.88 | CDK1 (0.74) | CDK1KDRCAMK2D | |
| SCHEMBL20817055 | 0.87 | CDK1 (0.76) | CDK1KDRCAMK2D | |
| SCHEMBL490791 | 0.86 | CDK1 (1.00) | CDK1KDR | |
| SCHEMBL6034007 | 0.79 | CDK1 (0.65) | CDK1KDRCAMK2D | |
| SCHEMBL6033288 | 0.79 | CDK1 (1.00) | CDK1KDR | |
| SCHEMBL6033997 | 0.78 | CDK1 (0.73) | CDK1KDR | |
| SCHEMBL6033306 | 0.78 | CDK1 (0.87) | CDK1KDR | |
| SCHEMBL6033958 | 0.77 | KDR (0.98) | CDK1KDR | |
| SCHEMBL4327703 | 0.74 | CDK1 (1.00) | CDK1KDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4240368-A1 | METHODS AND COMPOSITIONS FOR TREATING FIBROTIC DISEASES | MAX Biopharma, Inc. (US) | 2023-09-13 | — | — | EP | disclosed |
| WO-2022098907-A1 | METHODS AND COMPOSITIONS FOR TREATING FIBROTIC DISEASES | MAX BioPharma, Inc. (US) | 2022-05-12 | — | — | WO | disclosed |
| WO-2015195684-A2 | SMALL MOLECULE ANTI-SCARRING AGENTS | UNIVERSITY OF ROCHESTER (US) | 2015-12-23 | — | — | WO | disclosed |
| EP-2262530-A1 | METALLOPROTEINASE 12 BINDING PROTEINS | Dyax Corp. (US) | 2010-12-22 | — | — | EP | disclosed |
| EP-2262840-A2 | METALLOPROTEINASE 9 AND METALLOPROTEINASE 2 BINDING PROTEINS | Dyax Corp. (US) | 2010-12-22 | — | — | EP | disclosed |
| WO-2009111507-A1 | METALLOPROTEINASE 12 BINDING PROTEINS | DYAX CORP. (US) | 2009-09-11 | — | — | WO | disclosed |
| WO-2009111508-A2 | METALLOPROTEINASE 9 AND METALLOPROTEINASE 2 BINDING PROTEINS | DYAX CORP. (US) | 2009-09-11 | — | — | WO | disclosed |
| WO-2009097397-A2 | METALLOPROTEINASE BINDING PROTEINS | DYAX CORP. (US) | 2009-08-06 | — | — | WO | disclosed |
| EP-2073826-A2 | SEQUENTIAL COMBINATION THERAPY | Dyax Corporation (US) | 2009-07-01 | — | — | EP | disclosed |
| EP-1984522-A2 | METHODS OF INCREASING LYMPHATIC FUNCTION | The General Hospital Corporation (US) | 2008-10-29 | — | — | EP | disclosed |
| WO-2008048996-A9 | SEQUENTIAL COMBINATION THERAPY | DYAX CORP (US) | 2008-09-12 | — | — | WO | disclosed |
| WO-2008048996-A2 | SEQUENTIAL COMBINATION THERAPY | DYAX CORP. (US) | 2008-04-24 | — | — | WO | disclosed |
| WO-2007084599-A2 | METHODS OF INCREASING LYMPHATIC FUNCTION | THE GENERAL HOSPITAL CORPORATION (US) | 2007-07-26 | — | — | WO | disclosed |
| EP-1807451-A2 | HK1-BINDING PROTEINS | Dyax Corporation (US) | 2007-07-18 | — | — | EP | disclosed |
| WO-2006017538-A9 | HK1-BINDING PROTEINS | DYAX CORP (US) | 2006-03-30 | — | — | WO | disclosed |
| WO-2006017538-A2 | HK1-BINDING PROTEINS | DYAX CORP. (US) | 2006-02-16 | — | — | WO | disclosed |
| WO-2005097187-A2 | METHODS OF PREVENTING UVB-INDUCED SKIN DAMAGE | THE GENERAL HOSPITAL CORPORATION (US) | 2005-10-20 | — | — | WO | disclosed |